A high SFE dose effectively improved BW loss, reduced the FBG level, and recovered the serum lipid profile, GSP, GHb, and pancreatic morphological damage, thereby indicating its effects on alleviating T2DM progression. This evidence concerns the gene GNAS and type 2 diabetes mellitus.